The top 100 stock
market authors
selected for publication
market authors
selected for publication
Spectrum Pharmaceuticals, Inc. (SPPI)
()
- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- Analysis
- Articles
- Instablogs1 new
- StockTalks
- Sentiment
- Comments1 new
- News & PR
- Market Currents
- Buzz
- Twitter: SPPI
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
Analysis - Latest Articles by most recent | most commented
- Five Drug Makers with Pending Catalysts
- Spectrum Pharma: Zevalin Has Blockbuster Potential
- Spectrum Pharmaceuticals: Undervalued and (Now) Oversold
- Spectrum Pharmaceuticals: Rumors of Buyout Talks Persist
- These Small Cap Cancer Drugmakers Have Big Growth Potential
- Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
- Spectrum Pharmaceuticals: Outlook Remains Very Promising
- Spectrum Pharmaceuticals: Undervalued Growth Company with Strong Late-Stage Pipeline
- Spectrum Pharmaceuticals: The Labor Day Catalyst
- How Zevalin Is Helping Spectrum
- Pending FDA Decisions: 20 Extreme Trades
- 13 Extreme FDA Trades
- Which Has a Better Risk/Reward Ratio - Citigroup or Cell Genesys?
- Bayer's Bold New Bet Fails to Rain on Spectrum Pharma
- Spectrum Pharmaceuticals: Oversold and Undervalued
- Spectrum Pharma: Expect a Positive FDA Decision
- Vanda Pharma: An Extreme FDA Trade That Paid; 9 More to Go
- Two Possible Upcoming Approvals for Spectrum Pharmaceuticals
- Cell Therapeutics' Turnaround Remains on Track
- Ariad Pharmaceuticals: Advancing in Front of Phase 3 Interim Results
- Spectrum: FDA News on Zevalin Equals an Approval
- 15 Possible Healthcare Breakout Stocks
- 12 Extreme FDA Trades on New Product Decisions
- Cancer Stocks Hammered Once Again
- Cell Therapeutics Reemerging
- Spectrum Pharmaceuticals: Optimistic About Zevalin's Prospects
- Key Developments for Spectrum Pharma, Human Genome Sciences and Hemispherx Biopharma
- Tracking Cancer Diagnostic and Therapeutic Stocks
- On Small Cap Drug Makers and Volatility
- Spectrum Pharmaceuticals: Temporary Setback
-
The Seeking Alpha 100
See all
Seeking Alpha 100 » -
Fastest Climbers
Authors with the largestSee all
increase in followers
in the last 7 days
Fastest Climbers » -
Top Commenters
Top commenters,See all
as ranked by their peers
Top Commenters » -
Top Instabloggers
The 100 most active
Instabloggers.-
1
TraderMark
-
2
Don Dion
-
3
Cliff Wachtel
-
4
Mike Havrilla
-
5
James Quinn
Top Instabloggers » -
1
-
Top StockTalkers
TopSee all
StockTalkers.
Top StockTalkers »
